Bloodstream Infections Are an Improbable Cause of Positive Serum (1,3)-β-D-Glucan in Hematology Patients

被引：13

作者：

Furfaro, E. ^{[1
]}

Mikulska, M. ^{[1
]}

Del Bono, V. ^{[1
]}

Guolo, F. ^{[2
]}

Minetto, P. ^{[2
]}

Gobbi, M. ^{[2
]}

Ghiso, A. ^{[3
]}

Bacigalupo, A. ^{[3
]}

Viscoli, C. ^{[1
]}

机构：

[1] IRCCS San Martino IST Univ Hosp, Div Infect Dis, Genoa, Italy

[2] IRCCS San Martino IST Univ Hosp, Div Hematol, Genoa, Italy

[3] IRCCS San Martino IST Univ Hosp, Div Hematol & HSCT, Genoa, Italy

来源：

CLINICAL AND VACCINE IMMUNOLOGY | 2014年 / 21卷 / 09期

关键词：

INVASIVE FUNGAL-INFECTIONS; BETA-D-GLUCAN; 1,3-BETA-D-GLUCAN ASSAY; PSEUDOMONAS-AERUGINOSA; EARLY-DIAGNOSIS; ASPERGILLOSIS; GALACTOMANNAN; MALIGNANCIES; PERFORMANCE; REACTIVITY;

D O I：

10.1128/CVI.00214-14

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Ninety-one serum samples from 51 hematology patients with bacteremia infections were tested for (1,3)-beta-D-glucan (BG). Eleven samples (15%) from 7 patients (14%) were positive for BG. Of these 7 patients with positive BG results, 4 (8%) had invasive aspergillosis and 3 (6%) had no invasive fungal disease. Bacteremia was an unlikely cause of the false-positive BG results.

引用

页码：1357 / 1359

页数：3

共 50 条

[21] (1,3)-β-D-glucan assay for diagnosing invasive fungal infections in critically ill patients with hematological malignancies
Azoulay, Elie
Guigue, Nicolas
Darmon, Michael
Mokart, Djamel
Lemiale, Virginie
Kouatchet, Achille
Mayaux, Julien
Vincent, Francois
Nyunga, Martine
Bruneel, Fabrice
Rabbat, Antoine
Bretagne, Stephane
Lebert, Christine
Meert, Anne-Pascale
Benoit, Dominique
Pene, Frederic
ONCOTARGET, 2016, 7 (16) : 21484 - 21495
[22] Early serum (1→3)-β-D-glucan levels in patients with burn injury
Shupp, Jeffrey W.
Petraitiene, Ruta
Jaskille, Amin D.
Pavlovich, Anna R.
Matt, Sarah E.
Nguyen, Do T.
Kath, Melissa A.
Jeng, James C.
Jordan, Marion H.
Finkelman, Malcolm
Walsh, Thomas J.
Shoham, Shmuel
MYCOSES, 2012, 55 (03) : 224 - 227
[23] Bacteremia by Pseudomonas aeruginosa may cause elevated serum (1→3)-β-D-glucan levels
Held, J.
Grawitz, A. Busse
Friedrich, R.
Rappold, E.
Schulz, C.
MYCOSES, 2014, 57 : 33 - 33
[24] Clinical Usefulness of Serum (1,3)-β-D-glucan to predict invasive candidiasis in patients with severe burn trauma
Lee, Nuri
Kym, Dohern
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2022, 55 (01) : 138 - 146
[25] Performance of serum (1,3)-ß-d-glucan screening for the diagnosis of invasive aspergillosis in neutropenic patients with haematological malignancies
Furfaro, Elisa
Giacobbe, Daniele Roberto
Del Bono, Valerio
Signori, Alessio
Guolo, Fabio
Minetto, Paola
Clavio, Marino
Ballerini, Filippo
Gobbi, Marco
Viscoli, Claudio
Mikulska, Malgorzata
MYCOSES, 2018, 61 (09) : 650 - 655
[26] Interference of (1→3)-β-D-glucan Administration in the Measurement of Plasma (1→3)-β-D-glucan
Ishizuka, Y
Tsukada, H
Gejyo, F
INTERNAL MEDICINE, 2004, 43 (02) : 97 - 101
[27] Role of serum (1,3)-β-D-glucan assay in early diagnosis of invasive fungal infections in a neonatal intensive care unit
Shabaan, Abd Elazeez
Elbaz, Lobna Mahmoud
El-Emshaty, Wafaa M.
Shouman, Basma
JORNAL DE PEDIATRIA, 2018, 94 (05) : 559 - 565
[28] Presence of (1-3) β-D-Glucan in patients at risk for invasive fungal infections
Gonzalez, M.
Sanchez, C.
Velez, V. Posada
Segura, A.
Acevedo, J. J.
Tobon, A.
Arango, K.
MYCOSES, 2015, 58 : 112 - 112
[29] The Clinical Significance of Serum 1,3-β-D-Glucan For the Diagnosis of Candidemia in Severe Burn Patients
Kaita, Yasuhiko
Tarui, Takehiko
Otsu, Akiyasu
Tanaka, Yuya
Suzuki, Jun
Yoshikawa, Kei
Yamaguchi, Yoshihiro
JOURNAL OF BURN CARE & RESEARCH, 2019, 40 (01): : 104 - 106
[30] Lower sensitivity of serum (1,3)-β-D-glucan for the diagnosis of candidaemia due to Candida parapsilosis
Mikulska, M.
Giacobbe, D. R.
Furfaro, E.
Mesini, A.
Marchese, A.
Del Bono, V.
Viscoli, C.
CLINICAL MICROBIOLOGY AND INFECTION, 2016, 22 (07) : 646.e5 - 646.e8

← 1 2 3 4 5 →